Bolaji Akala M.D.

Bolaji Akala MD, PhD, is an accomplished professional in the field of oncology and clinical research, currently serving as the Scientific Associate Vice President and Head of Section 2 Early Oncology Clinical Research at Merck. Prior experience includes a Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center, a Visiting Researcher position in the Laboratory of Chromatin Biology and Epigenetics at The Rockefeller University, and an Internal Medicine Residency in the Clinical Investigator Pathway at Columbia University Irving Medical Center. Bolaji Akala also participated in the Medical Scientist Training Program (MD/PhD) at the University of Michigan Medical School, highlighting a strong foundation in both clinical and research domains.